nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1001 |
Synthesis and radiofluorination of [18F]F-BAY-8002: a novel potential radiotracer for PET imaging of monocarboxylate transporter 1
|
Sadeghzadeh, Masoud |
|
|
96-97 |
S |
p. S74-S75 |
artikel |
1002 |
Synthesis and radiolabeling of a novel decadentate ligand 3,4,3,3-(LI-1,2-HOPO)
|
Carbo-Bague, Imma |
|
|
96-97 |
S |
p. S12-S13 |
artikel |
1003 |
Synthesis and radiolabeling of [11C]CP31398 and fluorine-18 derivatives for PET imaging targeting p53
|
Beuché, Sébastien |
|
|
96-97 |
S |
p. S180 |
artikel |
1004 |
Synthesis and radiolabeling of diabody fragment of anti-PD-L1-B11 antibody for PET imaging of PD-L1 in a melanoma tumor mouse model
|
Bansal, Aditya |
|
|
96-97 |
S |
p. |
artikel |
1005 |
Synthesis and radiolabeling of ultrasmall gold nanoparticles for in vivo tracking of radiosensitizing agents in radiation therapy
|
Kiseleva, Mariia |
|
|
96-97 |
S |
p. S84 |
artikel |
1006 |
Synthesis and radiolabeling with carbon-11 of original covalent inhibitors of focal adhesion kinase for PET imaging
|
Beuché, Sébastien |
|
|
96-97 |
S |
p. S70-S71 |
artikel |
1007 |
Synthesis and radiolabelling of the anti-retroviral drug dolutegravir with fluorine-18 for PET imaging of HIV-1 reservoirs
|
Tisseraud, Marion |
|
|
96-97 |
S |
p. S78 |
artikel |
1008 |
Synthesis and translational evaluation of three novel PARP PET tracers in nonhuman primates and rodent glioma brain tumor model with intact blood-brain barrier
|
Tong, Jie |
|
|
96-97 |
S |
p. |
artikel |
1009 |
Synthesis, characterization and biodistribution of a new ‘2+1’ 99mTc/Re tricarbonyl complex bearing bis(2-hydroxyethyl) carbamodithioate and 4-anilinoquinazoline derivative
|
Makrypidi, Konstantina |
|
|
96-97 |
S |
p. S36-S37 |
artikel |
1010 |
Synthesis, characterization, and radiolabeling of a hexadentate chelate for [45Ti]Ti4+ radiopharmaceuticals
|
Carbo-Bague, Imma |
|
|
96-97 |
S |
p. |
artikel |
1011 |
Synthesis, Dosimetry and Pharm/tox studies of MAO-B Analogue ([11C]COU) for Positron Emission Tomographic Studies
|
Kaur, Tanpreet |
|
|
96-97 |
S |
p. |
artikel |
1012 |
Synthesis, in vitro and in vivo evaluation of novel radioligands for α-synuclein PET
|
Korat, Spela |
|
|
96-97 |
S |
p. |
artikel |
1013 |
Synthesis of a carbon-11 labeled imidazo[1,2-a]pyridine derivative as a new potential PET tracer for imaging of PI3K/mTOR in cancer
|
Liu, Wenqing |
|
|
96-97 |
S |
p. |
artikel |
1014 |
Synthesis of a carbon-11 labeled metabotropic glutamate receptor 7 ligand for PET neuroimaging
|
Xiao, Zhiwei |
|
|
96-97 |
S |
p. S112 |
artikel |
1015 |
Synthesis of a carbon-11 labeled spiro-quinazolinone based PDE7 ligand for PET neuroimaging
|
Xiao, Zhiwei |
|
|
96-97 |
S |
p. S111-S112 |
artikel |
1016 |
Synthesis of a 11C-labeled ketone through intermolecular arene C–H carbonylation from 4-iodotoluene and 1-methylindole
|
Lu, Shuiyu |
|
|
96-97 |
S |
p. S73 |
artikel |
1017 |
Synthesis of a 18F-labeled resveratrol derivative for integrin receptor imaging
|
Kim, Hyunjung |
|
|
96-97 |
S |
p. |
artikel |
1018 |
Synthesis of a new 6-substituted 4-anilinoquinazoline derivative as irreversible inhibitor for EGFR imaging
|
Makrypidi, Konstantina |
|
|
96-97 |
S |
p. S209 |
artikel |
1019 |
Synthesis of a porphyrin-PSMA conjugate and preliminary labelling with copper-64
|
Guttormsen, Yngve |
|
|
96-97 |
S |
p. S67-S68 |
artikel |
1020 |
Synthesis of a PSMA-targeting ligand with an optimized linker for imaging and treatment of prostate cancer
|
Murce, Erika |
|
|
96-97 |
S |
p. S206-S207 |
artikel |
1021 |
Synthesis of [11C]aryl nitriles via [11C]aryl amides
|
Gonzalez, Miguel Cortes |
|
|
96-97 |
S |
p. S71 |
artikel |
1022 |
Synthesis of [11C]Me-DPA and evaluation in transgenic mouse model of Alzheimer’s disease
|
Keller, Thomas |
|
|
96-97 |
S |
p. S25-S26 |
artikel |
1023 |
Synthesis of [64Cu]Cu+ complex for redox imaging and evaluation of its reactivity with reactive oxygen species
|
Tada, Tetsuro |
|
|
96-97 |
S |
p. |
artikel |
1024 |
Synthesis of [11C]uPSEM792 and Evaluation in Rodents as a Candidate PET Radioligand for Chemogenetic Research
|
Nerella, Sridhar Goud |
|
|
96-97 |
S |
p. |
artikel |
1025 |
Synthesis of esters and acids through two-step 11C-Carbonylation using GE TracerLab FX Synthesis modules
|
Kaur, Tanpreet |
|
|
96-97 |
S |
p. |
artikel |
1026 |
Synthesis of ethylenediaminotetramethylene phosphonic acid and I of freeze-dried kit for the preparation of a bone radiotracer [99mTc]Tc-EDTMP
|
Choutri, Intissar |
|
|
96-97 |
S |
p. S33 |
artikel |
1027 |
Synthesis of [18F]Aryl trifluoromethyl sulfones, -sulfoxides, and -sulfides
|
Veth, Lukas |
|
|
96-97 |
S |
p. |
artikel |
1028 |
Synthesis of [18F]FAraG Using a Second-Generation Precursor and Its Utility Across Multiple Radiochemistry Platforms
|
Blecha, Joseph |
|
|
96-97 |
S |
p. |
artikel |
1029 |
Synthesis of [18F]FPATPP via Cu-mediated 18F-fluorination
|
Lahdenpohja, Salla |
|
|
96-97 |
S |
p. S73-S74 |
artikel |
1030 |
Synthesis of fluorine-18 labeled glycogen synthase kinase-3 inhibitors and preliminary PET neuroimaging in rodent and non-human primate
|
Varlow, Cassis |
|
|
96-97 |
S |
p. S31-S32 |
artikel |
1031 |
Synthesis of fluorine-18 labelled tetrazine and coupling to trans-cyclooctene functionalized Affibody molecules
|
Zhang, Bo |
|
|
96-97 |
S |
p. S115 |
artikel |
1032 |
Synthesis of [18F]MK7246 for beta cell mass imaging
|
Parker, Candace |
|
|
96-97 |
S |
p. S40-S41 |
artikel |
1033 |
Synthesis of [18F]Togni reagent I, a new electrophilic [18F] trifluoromethylation synthon
|
Haveman, Lizeth |
|
|
96-97 |
S |
p. S15-S16 |
artikel |
1034 |
Synthesis of [18F]UCB-J
|
Keller, Thomas |
|
|
96-97 |
S |
p. S82 |
artikel |
1035 |
Synthesis of gold nanoparticles labeled with Auger electron emitters: 197Hg/197mHg as potential therapeutic radiopharmaceuticals
|
Majka, Emilia |
|
|
96-97 |
S |
p. S162 |
artikel |
1036 |
Synthesis of N-methyl- and 5-OH-[18F]fluorotryptophans
|
Kolks, Niklas |
|
|
96-97 |
S |
p. S34-S35 |
artikel |
1037 |
Synthesis of NOTA derivative bifunctional chelators for complexation of Re: Tc-tricarbonyl cores
|
Hoerres, Rebecca |
|
|
96-97 |
S |
p. S34-S35 |
artikel |
1038 |
Synthesis of novel PSMA ligands and preclinical evaluation of [99mTc]TcO-ABX474, a radioligand for SPECT imaging of prostate cancer
|
Ludwig, Friedrich-Alexander |
|
|
96-97 |
S |
p. S19 |
artikel |
1039 |
Synthesis of novel selective histone deacetylase inhibitors for the development of a suitable 18F-labelled radiotracer for the molecular imaging of HDAC1 in brain tumours
|
Clauß, Oliver |
|
|
96-97 |
S |
p. S215-S216 |
artikel |
1040 |
Synthesis of [13N]-Oxytocin for human intranasal administration
|
Jakobsen, Steen |
|
|
96-97 |
S |
p. S125 |
artikel |
1041 |
Synthesis of PET tracers for imaging of thiocyanate efflux from the brain
|
Okamura, Toshimitsu |
|
|
96-97 |
S |
p. S74 |
artikel |
1042 |
Synthesis of radiopharmaceuticals (At-AITM) for melanoma with overexpressed metabotropic glutamate receptor 1
|
Hanyu, Masayuki |
|
|
96-97 |
S |
p. S173-S174 |
artikel |
1043 |
Synthesis of Tritium-labeled Lu-PSMA-617: Alternative Tool for Biological Evaluation of Radiometal-based Pharmaceuticals
|
Bauder-Wuest, Ulrike |
|
|
96-97 |
S |
p. |
artikel |
1044 |
Synthesis, radiolabeling and biological evaluation of a novel trace amine-associated receptor 1 (TAAR1) PET radioligand
|
Haider, Ahmed |
|
|
96-97 |
S |
p. S37-S38 |
artikel |
1045 |
Synthesis, radiolabeling and fluorescence imaging of new fluorine-18 derivatives of MeDAS for PET imaging of demyelination
|
Beuché, Sébastien |
|
|
96-97 |
S |
p. S89-S90 |
artikel |
1046 |
Synthesis, radiolabeling and metabolism of new fluorine-18 derivatives of MeDAS for PET imaging of demyelination
|
Beuché, Sébastien |
|
|
96-97 |
S |
p. S72-S73 |
artikel |
1047 |
Synthesis, radiolabelling and complex formation of the novel chelator DOTI-Me with Cu, In, Ga
|
Hierlmeier, Ina |
|
|
96-97 |
S |
p. S4-S5 |
artikel |
1048 |
Synthesis/radiosynthesis and evaluation of three 18F radiotracers for imaging of sphingosine-1-phosphate receptor 1
|
Qiu, Lin |
|
|
96-97 |
S |
p. S4 |
artikel |
1049 |
Synthetic methodologies toward fibroblast activation protein inhibitors and radiolabelling with 68Ga, 64Cu or 89Zr
|
Flores, Jose Esteban |
|
|
96-97 |
S |
p. S94-S95 |
artikel |
1050 |
Systematic evaluation of size and net charge of antibody after bioconjugation and radiolabeling
|
Byeon, Gyeong-Tak |
|
|
96-97 |
S |
p. |
artikel |
1051 |
Systematic Side-by-Side Comparison of Five Different PARP Radiotracers in an HR-Deficient Breast Cancer Xenograft Model
|
Stotz, Sophie |
|
|
96-97 |
S |
p. |
artikel |
1052 |
Table of Contents
|
|
|
|
96-97 |
S |
p. iv |
artikel |
1053 |
Targeted alpha tumour therapy and other oncological solutions (TATTOOS) as part of Paul Scherrer Institute’s IMPACT large facilities project
|
van der Meulen, Nicholas |
|
|
96-97 |
S |
p. S48 |
artikel |
1054 |
Targeted 212Pb therapy in prostate cancer xenograft mouse model using a novel clinical-stage human monoclonal antibody
|
Li, Jun |
|
|
96-97 |
S |
p. S192 |
artikel |
1055 |
Targeted radioimmunotherapy of PD1+ cells for the treatment of multiple sclerosis
|
Frank, Connor |
|
|
96-97 |
S |
p. S4-S5 |
artikel |
1056 |
Targeting brain tumours with radiolabelled chlorotoxin, a scorpion venom peptide
|
Zafar, Iman |
|
|
96-97 |
S |
p. |
artikel |
1057 |
Targeting LDLR-overexpressing glioblastoma and pancreatic ductal adenocarcinoma
|
Tworowska, Izabela |
|
|
96-97 |
S |
p. S217-S218 |
artikel |
1058 |
Targeting mammary-derived growth inhibitor for positron emission tomography imaging of breast cancer brain metastasis
|
Dillemuth, Pyry |
|
|
96-97 |
S |
p. |
artikel |
1059 |
Targeting the aryl hydrocarbon receptor to monitor the kynurenine pathway in glioblastoma multiforme using fluorine-18 PET radiotracers
|
Lim, Ting Xiang |
|
|
96-97 |
S |
p. |
artikel |
1060 |
Targeting the kynurenine pathway for tumour characterization by PET and SPECT
|
Foscolos, Angeliki |
|
|
96-97 |
S |
p. S182-S183 |
artikel |
1061 |
Targeting α2δ1 with a 64Cu-NOTA-1B50-1-F(ab`)2 enables in vivo PET imaging of liver cancer stem cells
|
Guo, Xiaoyi |
|
|
96-97 |
S |
p. S189-S190 |
artikel |
1062 |
Target occupancy studies of rho-associated protein kinase inhibitors in nonhuman primate with [11C]ROCK201 PET
|
Zheng, Chao |
|
|
96-97 |
S |
p. |
artikel |
1063 |
Technetium and rhenium complexes with potential against glioblastomas
|
Salsi, Federico |
|
|
96-97 |
S |
p. S39 |
artikel |
1064 |
Tetrazine ligation based pretargeting strategy for core-labeled polymeric micelles
|
Sporer, Emanuel |
|
|
96-97 |
S |
p. S13-S14 |
artikel |
1065 |
232Th(d,4n)230Pa cross-section measurements at ARRONAX facility for the production of 230U
|
Duchemin, C. |
|
2014 |
96-97 |
S |
p. e19-e22 nvt p. |
artikel |
1066 |
The bioconjugation of a radioiodinated silicon rhodamine as multimodal imaging probe for SPECT and NIR imaging
|
Kanagasundaram, Thines |
|
|
96-97 |
S |
p. S168-S169 |
artikel |
1067 |
The biodistribution of [18F]BPA in nude mice bearing U87MG glioma
|
Fenglin, Li |
|
|
96-97 |
S |
p. S101-S102 |
artikel |
1068 |
The CERN-MEDICIS facility: a radioisotope production facility for medical applications
|
Lambert, Laura |
|
|
96-97 |
S |
p. S46 |
artikel |
1069 |
The chelate makes the difference: Positively charged copper complexes favor receptor affinity and cell internalization of gastrin-releasing peptide receptor agonists and antagonists
|
Stemler, Tobias |
|
|
96-97 |
S |
p. |
artikel |
1070 |
The development of a dual-modality (PET/NIR) radioimmunoconjugate for image-guided sarcoma surgery
|
Pringle, Toni |
|
|
96-97 |
S |
p. S169 |
artikel |
1071 |
The development of [11C]M503-1619 as a PET tracer for imaging α-synucleinopathies in Parkinson’s disease (PD)
|
Tian, Guilong |
|
|
96-97 |
S |
p. |
artikel |
1072 |
The development of heparanase-targeting radiotracers for PET imaging
|
Pu, Yinglan |
|
|
96-97 |
S |
p. S210 |
artikel |
1073 |
The development of terbium-155 and terbium-161 towards radiotheragnostic clinical applications
|
Favaretto, Chiara |
|
|
96-97 |
S |
p. S44 |
artikel |
1074 |
The effect of base strengths on the radiochemical yields of S[18F]FB synthesis
|
Al-Qahtani, Mohammed |
|
|
96-97 |
S |
p. S75-S76 |
artikel |
1075 |
The evaluation of enzyme-mediated forms of [18F]AlF-RESCA-VHH5v2 exemplified with human CD8 PET imaging
|
Gill, Herman |
|
|
96-97 |
S |
p. |
artikel |
1076 |
The first radioiodinated protein affinity probe for estrogen receptor targeted breast cancer imaging
|
Fang, Jianyang |
|
|
96-97 |
S |
p. S52-S53 |
artikel |
1077 |
The hydrazone modified HYNIC-PSMA inhibitor - a stable ligand for 99mTc-labelling
|
Pijarowska-Kruszyna, Justyna |
|
|
96-97 |
S |
p. |
artikel |
1078 |
The influence of terminal amine groups in close proximity to the metal chelator in peptide derived radiopharmaceuticals on the radiolabelling with 68Ga and 64Cu
|
Hierlmeier, Ina |
|
|
96-97 |
S |
p. S150 |
artikel |
1079 |
The journey towards PET imaging with copper-61: From GMP production of the radiopharmaceutical precursor to in vivo imaging
|
Fonseca, Alexandra |
|
|
96-97 |
S |
p. |
artikel |
1080 |
The Next Generation of Tumour Homing Peptides: Foldamers at the Forefront of Precise Cancer Theranostics
|
Rahimi, Marwa Nadia |
|
|
96-97 |
S |
p. |
artikel |
1081 |
Theoretical and experimental study of astatine-metal bonds: towards new 211At-labelling approaches based on transition metal complexes
|
Ligeour, Mathilde |
|
|
96-97 |
S |
p. |
artikel |
1082 |
Theoretical evaluation of losartan derivatives with polar sidechains as candidates of radiopharmaceutical
|
Fleitas, Ariel Garcia |
|
|
96-97 |
S |
p. S79 |
artikel |
1083 |
The (Pre)Clinical Potential of Targeted Radionuclide Therapy with Terbium-161
|
Ntihabose, Carolline |
|
|
96-97 |
S |
p. |
artikel |
1084 |
The production of radionuclides for nuclear medicine from a compact, low-energy accelerator system
|
Webster, William D. |
|
2014 |
96-97 |
S |
p. e7-e15 nvt p. |
artikel |
1085 |
The production of 161Tb and its introduction to the clinic through the Good Manufacturing Practice-compliant radiolabeling of [161Tb]Tb-DOTATOC
|
Favaretto, Chiara |
|
|
96-97 |
S |
p. S62-S63 |
artikel |
1086 |
The radiolabeling of silicon rhodamines for multimodal PET/ SPECT- and NIR optical imaging
|
Kanagasundaram, Thines |
|
|
96-97 |
S |
p. S81 |
artikel |
1087 |
Theranostic tetrazines: radiosynthesis and evaluation of aromatic 18F/211At pair highly reactive tetrazines for pretargeted bioorthogonal PET imaging and targeted alpha-therapy
|
Vázquez, Rocío García |
|
|
96-97 |
S |
p. S55-S56 |
artikel |
1088 |
The synthesis and bioevaluation of a novel and brain penetrable PARP1 tracer [18F]Pamiparib in rodents and nonhuman primates
|
Tong, Jie |
|
|
96-97 |
S |
p. S214-S215 |
artikel |
1089 |
The synthesis and evaluation of [68Ga]Ga-HBED-CC-TfRB1G3 for TfR1 imaging.
|
Lin, Longxin |
|
|
96-97 |
S |
p. |
artikel |
1090 |
The Synthesis, DoE Optimization, and Automation of the CLIPtag Radiotracer [18F]pFBC and its Evaluation in a Murine Brain Viral Gene Transfer Model
|
Bowden, Gregory |
|
|
96-97 |
S |
p. |
artikel |
1091 |
The synthesis of [11C]phosgene and its use in the synthesis of [2-11C] thymine
|
Salo, Simo |
|
|
96-97 |
S |
p. |
artikel |
1092 |
The theranostic Goldilocks radionuclide copper-67 produced at a biomedical cyclotron
|
Søndergaard, Ursula |
|
|
96-97 |
S |
p. S47-S48 |
artikel |
1093 |
The value of 18F-FDG PET/CT in differential diagnosis of pulmonary sclerosing pneumocytoma and pulmonary carcinoids
|
Zhang, Annan |
|
|
96-97 |
S |
p. S49-S50 |
artikel |
1094 |
Thiacrown Ligands for Encapsulation of Mercury-197 m/g into Radiopharmaceuticals
|
Randhawa, Parmissa |
|
|
96-97 |
S |
p. |
artikel |
1095 |
Thin layer chromatography for rapid purification and reformulation of microfluidically-produced radiopharmaceuticals
|
Holloway, Travis |
|
|
96-97 |
S |
p. S63-S64 |
artikel |
1096 |
[45Ti]Ti-HOPO radiochemistry for development of PET radiopharmaceuticals
|
Saini, Shefali |
|
|
96-97 |
S |
p. |
artikel |
1097 |
Title Page
|
|
|
|
96-97 |
S |
p. ii |
artikel |
1098 |
Title Page
|
|
|
|
96-97 |
S |
p. i |
artikel |
1099 |
Title Page
|
|
|
|
96-97 |
S |
p. |
artikel |
1100 |
Toward a reproductive and automated radiolabelling with {Al18F}2+ complex? A full comparison with the radiolabelling of small molecules
|
Schmitt, Sébastien |
|
|
96-97 |
S |
p. S86-S87 |
artikel |
1101 |
Towards Actinium-225 production at SCK CEN
|
Skliarova, Hanna |
|
|
96-97 |
S |
p. S80-S81 |
artikel |
1102 |
Towards an improved methodology for separating mercury-197 from proton-irradiated gold targets – a study of mercury adsorption behaviour on different extraction resins in hydrochloric acid
|
Chen, Shaohuang |
|
|
96-97 |
S |
p. S93 |
artikel |
1103 |
Towards bifunctional and heteroleptic technetium isocyanide complexes
|
Claude, Guilhem |
|
|
96-97 |
S |
p. S33-S34 |
artikel |
1104 |
Towards bifunctional chelators for thallium-201 for use in nuclear medicine
|
Rigby, Alex |
|
|
96-97 |
S |
p. S10 |
artikel |
1105 |
Towards bifunctional technetium isonitrile complexes
|
Claude, Guilhem |
|
|
96-97 |
S |
p. S9-S10 |
artikel |
1106 |
Towards Carbon-11 Radiolabelling of Amino Acids Via Palladium Mediated C-H Functionalisation Reactions
|
Miller, Philip |
|
|
96-97 |
S |
p. |
artikel |
1107 |
Towards covalent fibroplast activation protein (FAP) inhibitors for delivery of therapeutic radionuclides into FAP-positive tumors
|
Humpert, Swen |
|
|
96-97 |
S |
p. |
artikel |
1108 |
Towards decreased Protodeboronation in the Late-Stage Copper-Mediated Radiofluorination of the Positron Emission Tomography Tracer for Tropomyosin Receptor Kinase [18F]TRACK
|
Jaworski, Carolin |
|
|
96-97 |
S |
p. |
artikel |
1109 |
Towards pretargeted PET imaging of Programmed Death Ligand 1 (PD-L1) with a gallium-68-labeled tris(hydroxypyridinone)-tetrazine
|
Centanni, Alessia |
|
|
96-97 |
S |
p. |
artikel |
1110 |
Towards sustainable production of gallium-68: recovery of gallium-68 and zinc from HNO3-based cyclotron liquid target by liquid-liquid extraction with amino phosphonates
|
Zhuravlev, Fedor |
|
|
96-97 |
S |
p. S14 |
artikel |
1111 |
Towards the development of 99mTc-based 5-HT1A imaging agents: synthesis and characterization of a Re(CO)3Cp analogue of WAY100635
|
Kapella, Anna |
|
|
96-97 |
S |
p. S35 |
artikel |
1112 |
Traceless Solid Phase Radiochemistry: A Novel Fluorine-18 Strategy for High Purity, High Molar Activity, No Purification, No Reformulation
|
Parker, Matthew |
|
|
96-97 |
S |
p. |
artikel |
1113 |
Tracking Intravenously Injected Micro- and Nanoplastics with PET
|
Delaney, Samantha |
|
|
96-97 |
S |
p. |
artikel |
1114 |
Trafficking of orally administered vitamins in mice with positron emission tomography
|
Bongarzone, Salvatore |
|
|
96-97 |
S |
p. S56-S57 |
artikel |
1115 |
Trans-cyclooctene modified antibodies for pretargeted imaging of amyloid-β
|
van den Broek, Sara Lopes |
|
|
96-97 |
S |
p. S98-S99 |
artikel |
1116 |
Transition-metal-free reductive coupling of an 18F-labeled nitro-arene with boronic acids as a potential access to 18F-labeled fenamates
|
Laube, Markus |
|
|
96-97 |
S |
p. S74 |
artikel |
1117 |
Translating radioimmunotherapy from cancer to infectious diseases
|
Dadachova, Ekaterina |
|
|
96-97 |
S |
p. S64-S65 |
artikel |
1118 |
Translational Development of [18F]Cholestify – Probing Brain Cholesterol Clearance in Alzheimer’s Disease
|
Zhao, Chunyu |
|
|
96-97 |
S |
p. |
artikel |
1119 |
Translational PET imaging evaluation of [18F]Favipiravir by positron emission tomography
|
Rong, Jian |
|
|
96-97 |
S |
p. S54 |
artikel |
1120 |
Translation of [68Ga]Ga-PSMA-11 radiosynthesis on the microfluidic system iMiDEVTM
|
Ovdiichuk, Olga |
|
|
96-97 |
S |
p. S134 |
artikel |
1121 |
Translation of New Chemical Methods and Radiopharmaceuticals for Neuroimaging
|
Vasdev, Neil |
|
|
96-97 |
S |
p. S2 |
artikel |
1122 |
Trastuzumab-conjugated oxine-based ligand for [89Zr] Zr4+-immunoPET
|
Southcott, Lily |
|
|
96-97 |
S |
p. S9 |
artikel |
1123 |
Treatment of prostate cancer xenografts with the targeted alpha-particle nanogenerator [225Ac]Ac-DOTA-YS5
|
Bidkar, Anil |
|
|
96-97 |
S |
p. S31 |
artikel |
1124 |
Triaza-18-Crown-6 Macrocycle Scaffold: Chelator Platform for Theranostic Application
|
Fiaccabrino, Desiree |
|
|
96-97 |
S |
p. |
artikel |
1125 |
Triaza-18-crown-6 macrocyclic chelators for the [203:212Pb]Pb2+ theranostic pair
|
Fiaccabrino, Desiree |
|
|
96-97 |
S |
p. S66 |
artikel |
1126 |
TRIGA Reactor Production and Synergistic Separation of 161Tb from Enriched 160Gd Targets Using Novel Extraction Chromatographic Resins
|
Holiski, Connor |
|
|
96-97 |
S |
p. |
artikel |
1127 |
TRIHOPO: 1,2-HOPO-based macrocyclic chelator for 225Ac, 227Th, and 89Zr
|
Fiaccabrino, Desiree |
|
|
96-97 |
S |
p. S55 |
artikel |
1128 |
Tryptophan 2,3-dioxygenase (TDO): the new promising target of 18F PET tracers as markers of neuroinflammationTryptophan 2,3-dioxygenase (TDO) : the new promising target of 18F PET tracers as markers of neuroinflammation
|
Vercouillie, Johnny |
|
|
96-97 |
S |
p. |
artikel |
1129 |
TSPO-targeted fluorescence and PET imaging for detection of bladder cancer
|
Lee, Won Chang |
|
|
96-97 |
S |
p. |
artikel |
1130 |
Tumor cell imaging with derivatives of Senicapoc targeting KCa3.1 channels
|
Konken, Christian |
|
|
96-97 |
S |
p. S76-S77 |
artikel |
1131 |
Tumor-self Targeting Potential of [89Zr]Zr-Oxinate4 Labeled PC3 and 4T1 Cells in Mice Bearing PC3 and 4T1 Tumors
|
Tekin, Volkan |
|
|
96-97 |
S |
p. |
artikel |
1132 |
Tumor-specific delivery of radioligands targeting carbonic anhydrase-IX utilizing albumin binder
|
Iikuni, Shimpei |
|
|
96-97 |
S |
p. S25-S26 |
artikel |
1133 |
Tumor stroma diagnostic imaging by a 68Ga-coupled small-molecule fibroblast activation protein (FAP) inhibitor: first pre-clinical data
|
Escudero-Castellanos, Alondra |
|
|
96-97 |
S |
p. S186-S187 |
artikel |
1134 |
Two HER2 PET tracers: Al18F-NOTA-HER2-BCH and Al18F-RESCA-HER2-BCH were compared
|
Liu, Jiayue |
|
|
96-97 |
S |
p. S201-S202 |
artikel |
1135 |
Ultra-fast and efficient conversion of [11C]CO2 into [11C]hydantoins via the Bucherer-Bergs multicomponent reaction
|
van der Aa, Frank |
|
|
96-97 |
S |
p. |
artikel |
1136 |
Uncovering the role of modified citrus pectin in cancer
|
da Silva, Fábio Alves |
|
|
96-97 |
S |
p. S176-S177 |
artikel |
1137 |
Unlocking the full Potential of N-suc-DFO-mAbs for 89Zr-Immuno-PET: A new method on Mild Removal of Iron from Fe-DFO-N-suc-mAb Complexes
|
Wuensche, Thomas |
|
|
96-97 |
S |
p. |
artikel |
1138 |
Using high-specific activity Samarium-153 for the development of [153Sm] Sm DOTA-TATE for targeted radionuclide therapy of neuroendocrine tumors
|
Vermeulen, Koen |
|
|
96-97 |
S |
p. S20 |
artikel |
1139 |
Utilizing click chemistry for PET infection imaging by fluorine-18 labeling of azide-modified bacteria
|
Alanizi, Aryn |
|
|
96-97 |
S |
p. S62 |
artikel |
1140 |
Validating the impact of metal contaminants on the radiolabeling of DOTATATE with 161Tb
|
Opsomer, Tomas |
|
|
96-97 |
S |
p. |
artikel |
1141 |
Versatile diphosphine platforms for molecular radio-pharmaceuticals based on technetium-99m and rhenium-188
|
Ma, Michelle |
|
|
96-97 |
S |
p. S35-S36 |
artikel |
1142 |
Visualizing SCLC in advanced murine models via immunoPET with a 89Zr-labeled radioimmunoconjugate
|
Sarrett, Samantha |
|
|
96-97 |
S |
p. S24-S25 |
artikel |
1143 |
Water-soluble [Tc(N)(PNP)]-moiety for the room temperature labeling of sensitive molecules
|
Bolzati, Cristina |
|
|
96-97 |
S |
p. S147 |
artikel |
1144 |
What a difference an additional methylene makes: replacing Glu with Aad in the Lys-urea-Glu pharmacophore to reduce kidney and salivary gland uptake of PSMA-targeting radiopharmaceuticals
|
Kuo, Hsiou-Ting |
|
|
96-97 |
S |
p. S200 |
artikel |
1145 |
86Y from recycled 86SrO targets
|
Aluicio-Sarduy, Eduardo |
|
|
96-97 |
S |
p. |
artikel |
1146 |
86Y/90Y-labeled ultrasmall porous silica nanoparticles with enhanced pharmacokinetics for cancer theranostics
|
Cai, Weibo |
|
|
96-97 |
S |
p. S160-S161 |
artikel |
1147 |
89Zr cyclotron-based production by a suitable Y solid target
|
Cisternino, Sara |
|
|
96-97 |
S |
p. S12 |
artikel |
1148 |
89Zr-immuno-PET guided preclinical development of targeted therapies: demonstrating utility by evaluating fusion proteins in vivo
|
Alvarez, Natalia Herrero |
|
|
96-97 |
S |
p. S54 |
artikel |
1149 |
89Zr-immuno-PET imaging: from liquid target production to imaging
|
Hrynchak, Ivanna |
|
|
96-97 |
S |
p. S23-S24 |
artikel |
1150 |
89Zr-immuno-PET of a novel bispecific amyloid-β monoclonal antibody reveals improved and high specific brain uptake
|
Stergiou, Natascha |
|
|
96-97 |
S |
p. S30-S31 |
artikel |
1151 |
89Zr-photoradiosynthesis of a dual-modality PET-optical tracer using light-induced antibody conjugation chemistry
|
Guillou, Amaury |
|
|
96-97 |
S |
p. S21-S22 |
artikel |
1152 |
89Zr radiolabeling of antibodies targeting trachea colonization factor A for immuno-PET imaging of Bodetella pertussis in whooping cough infection
|
Caillé, Fabien |
|
|
96-97 |
S |
p. S55 |
artikel |
1153 |
[89Zr]Zr-DFO-denosumab immuno-PET validation in the tumor microenvironment of human ME-180 xenografts
|
Dewulf, Jonatan |
|
|
96-97 |
S |
p. S1 |
artikel |
1154 |
[89Zr]Zr(oxinate)4 radiolabelling of human neutrophil extracellular microvesicles (EVs): in vivo PET imaging reveals extensive uptake in lymph nodes and brain in a mouse model of rheumatoid arthritis
|
de Rosales, Rafael T.M. |
|
|
96-97 |
S |
p. S20-S21 |
artikel |
1155 |
[89Zr]ZrTrastuzumab automatic preparation on commercial cassette base synthesis module
|
Cazzola, Emiliano |
|
|
96-97 |
S |
p. S122 |
artikel |